Détail du document
Identifiant

doi:10.1186/s43055-023-01072-3...

Auteur
Ahmad, Warda Rubab, Nayyar Gillani, Farkhanda Afzal, Muhammad Shahzad Ahmad, Barira Ahmad, Wajiha Imran, Muhammad Babar
Langue
en
Editeur

Springer

Catégorie

Medicine & Public Health

Année

2023

Date de référencement

02/08/2023

Mots clés
epiphora dacryoscintigraphy nasolacrimal duct obstruction papillary thyroid carcinoma thyroglobulin duct uptake cancer obstruction body left nasolacrimal scan thyroid
Métrique

Résumé

Background Radioactive iodine 131 (I-131) is used in the treatment of differentiated thyroid cancer after thyroidectomy; however, its accumulation in non-thyroidal regions may give false positive results on iodine whole body scan (WBS).

Only a few cases of radioiodine uptake in the orbital region in patients with thyroid cancer have been reported, which could be due to metastasis or false positive causes resulting from contamination or inflammatory etiology.

Case presentation We describe a case of 49-year-old male with history of papillary thyroid carcinoma.

The follow-up I-131 whole body scan showed a focus of increased radiotracer uptake in the region of left orbit.

Correlative single photon emission computed tomography (SPECT-CT) showed that uptake was due to stenosis of the left nasolacrimal duct causing obstructive symptoms on left side.

Dacryoscintigraphy also demonstrated significant obstruction of left nasolacrimal system.

Conclusions The nasolacrimal duct obstruction is a rare adverse event after I-131 therapy that can result in an accumulation of radioiodine on whole body scan, mimicking metastasis.

The use of additional spot views and SPECT-CT images along with thyroglobulin levels can help physicians in clarifying the situation in these uncertain cases.

Ahmad, Warda,Rubab, Nayyar,Gillani, Farkhanda,Afzal, Muhammad Shahzad,Ahmad, Barira,Ahmad, Wajiha,Imran, Muhammad Babar, 2023, Incidental detection of acquired unilateral nasolacrimal duct obstruction on I-131 whole body scan following I-131 therapy for thyroid cancer: a case report, Springer

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced